Article

Dementia drug demonstrates efficacy, safety in CPPS

Author(s):

Urology Times staff

Dr. Jordan Dimitrakov discusses the use of memantine in chronic pelvic pain syndrome with Urology Times.

Related Videos
Mitchell Huang, MD, on the link between obesity and pain on transperineal biopsy
Mitchell Huang, MD, on the link between obesity and pain on transperineal biopsy
Administering onabotA: Improving patient comfort and easing anxiety
Administering onabotA: Improving patient comfort and easing anxiety
Yahir A. Santiago-Lastra, MD, answers a question during a Zoom video interview
Yahir A. Santiago-Lastra, MD, discusses barriers to vaginal estrogen access
1 expert is featured in this series.
Factors Contributing to Higher Incidence and Worse Outcomes of mHSPC in Black Men
1 expert is featured in this series.
The Incidence of Prostate Cancer and Risk of Progression in Black Men
Woman talking with a doctor | Image Credit: © Liudmila Dutko - stock.adobe.com
Expert discusses genitourinary syndrome of menopause guidelines
2 experts are featured in this series.
The Biggest Challenges in Distinguishing ccRCC From Benign Renal Masses
2 experts are featured in this series.
The Evolvement of Imaging in ccRCC
Rebecca A. Campbell, MD, answers a question during a Zoom video interview
Rebecca A. Campbell, MD, discusses citation rates for men and women in the oncology literature
Joshua Heiman, MD, on phentermine plus topiramate for uric acid stone prevention
Joshua Heiman, MD, on phentermine plus topiramate for uric acid stone prevention
Related Content
Enrollment progresses in study for cisplatin-induced hearing loss in testicular cancer
May 14th 2025

Enrollment progresses in study for cisplatin-induced hearing loss in testicular cancer

Hannah Clarke
ACOU085 will be administered in 1 ear, with a matching placebo injection in the respective contralateral middle ear.
Pearls & Perspectives: Expanding BPH care & patient choice, with Kevin Zorn, MD, at AUA 25
May 4th 2025

Pearls & Perspectives: Expanding BPH care & patient choice, with Kevin Zorn, MD, at AUA 25

Amy M. Pearlman, MD Kevin C. Zorn, MD, FRCSC, FACS
Urologists discuss innovative BPH treatments, emphasizing personalized care, and the importance of ejaculatory preservation.
Conceptual image for prostate cancer treatment, 3D illustration showing destruction of a tumor inside prostate gland | Image Credit: © Dr_Microbe - stock.adobe.come
May 13th 2025

MRI and focal therapy may enable men on AS to safely delay surgery or radiation

Hannah Clarke
Use of focal therapy was shown to prolong the duration of active surveillance.
Pearls & Perspectives: Understanding and addressing priapism, with Serge Carrier, MD, and Gregory Broderick, MD
May 2nd 2025

Pearls & Perspectives: Understanding and addressing priapism, with Serge Carrier, MD, and Gregory Broderick, MD

Amy M. Pearlman, MD
Experts discuss urgent priapism management strategies, emphasizing timely intervention and collaboration for optimal patient outcomes.
Disitamab vedotin plus toripalimab extends PFS, OS in HER2-positive la/mUC
May 12th 2025

Disitamab vedotin plus toripalimab extends PFS, OS in HER2-positive la/mUC

Hannah Clarke
The phase 3 RC48-C016 trial met its primary end points.
Blur image of hospital corridor | Image Credit: © zephyr_p - stock.adobe.com
May 11th 2025

We got a little MIST-y at this year’s AUA Annual Meeting

Garrett D. Pohlman, MD
Urologist Garrett D. Pohlman, MD, reflects on the benign prostatic hyperplasia offerings from the 2025 American Urological Association Annual Meeting.
© 2025 MJH Life Sciences

All rights reserved.